Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging

Vemuri P, Fields J, Peter J, Klöppel S.

Curr Opin Neurol. 2016 Aug;29(4):405-11. doi: 10.1097/WCO.0000000000000346.

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Montine TJ, Banks WA, Zhang J.

Alzheimers Dement. 2016 Nov;12(11):1125-1131. doi: 10.1016/j.jalz.2016.04.003. Epub 2016 May 24.

TFEB at a glance

Napolitano G, Ballabio A.

J Cell Sci. 2016 Jul 1;129(13):2475-81. doi: 10.1242/jcs.146365. Epub 2016 Jun 1.

Neurologic Diseases in Special Care Patients

Robbins MR.

Dent Clin North Am. 2016 Jul;60(3):707-35. doi: 10.1016/j.cden.2016.03.002.

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)

Singh NA, Mandal AK, Khan ZA.

Nutr J. 2016 Jun 7;15(1):60. doi: 10.1186/s12937-016-0179-4.

Distribution of PSA-NCAM in normal, Alzheimer's and Parkinson's disease human brain

Murray HC, Low VF, Swanson ME, Dieriks BV, Turner C, Faull RL, Curtis MA.

Neuroscience. 2016 Aug 25;330:359-75. doi: 10.1016/j.neuroscience.2016.06.003. Epub 2016 Jun 7.

[Comparison of naming impairment among patients with Parkinson's disease without dementia, Parkinson's disease dementia and Alzheimer's disease]

Gui XH, Wang LP, Wu CL, Sun XF.

Zhonghua Yi Xue Za Zhi. 2016 Jun 7;96(21):1664-7. doi: 10.3760/cma.j.issn.0376-2491.2016.21.010.

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

Abdelnour C, van Steenoven I, Londos E, Blanc F, Auestad B, Kramberger MG, Zetterberg H, Mollenhauer B, Boada M, Aarsland D; European DLB Consortium.

Mov Disord. 2016 Aug;31(8):1203-8. doi: 10.1002/mds.26668. Epub 2016 Jun 14.

The Evolution of Genetics: Alzheimer's and Parkinson's Diseases

Singleton A, Hardy J.

Neuron. 2016 Jun 15;90(6):1154-1163. doi: 10.1016/j.neuron.2016.05.040.

A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease

McGhee DJ, Ritchie CW, Zajicek JP, Counsell CE.

BMC Neurol. 2016 Jun 16;16:92. doi: 10.1186/s12883-016-0606-3.

Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis?

Hofer T, Perry G.

J Trace Elem Med Biol. 2016 Dec;38:1-9. doi: 10.1016/j.jtemb.2016.06.005. Epub 2016 Jun 7.

[Endogenous Cannabinoid System of the Brain as the Target for Influences at Neurodegenerate Diseases]

Kitchigina VF.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2016 Jul;66(4):387-413.

Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer's Disease are Associated with Parkinsonism

Brønnick K, Breitve MH, Rongve A, Aarsland D.

J Alzheimers Dis. 2016 Jun 30;53(4):1277-85. doi: 10.3233/JAD-160294.

Metallo-pathways to Alzheimer's disease: lessons from genetic disorders of copper trafficking

Greenough MA, Ramírez Munoz A, Bush AI, Opazo CM.

Metallomics. 2016 Sep 1;8(9):831-9. doi: 10.1039/c6mt00095a. Epub 2016 Jul 11.

(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study

Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C; SCILLA Working Group.

Ann Neurol. 2016 Sep;80(3):368-78. doi: 10.1002/ana.24717. Epub 2016 Aug 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias